Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 598,100 | 647,300 | 369,400 | 1,518,700 | 1,517,300 |
| Receivables | 2,265,200 | 2,276,700 | 2,274,500 | 2,097,000 | 2,224,800 |
| Inventories | 521,500 | 508,100 | 488,300 | 493,200 | 483,100 |
| TOTAL | $4,078,800 | $4,087,200 | $3,789,700 | $4,806,500 | $4,909,900 |
| Non-Current Assets | |||||
| PPE Net | 3,112,800 | 3,133,800 | 3,090,800 | 3,045,400 | 3,050,000 |
| Investments And Advances | 168,200 | 160,400 | 168,000 | 16,300 | 16,900 |
| Intangibles | 10,253,700 | 10,045,500 | 9,908,300 | 9,858,600 | 10,023,100 |
| Other Non-Current Assets | 648,100 | 633,000 | 647,000 | 652,200 | 612,600 |
| TOTAL | $14,182,800 | $13,972,700 | $13,814,100 | $13,572,500 | $13,702,600 |
| Total Assets | $18,261,600 | $18,059,900 | $17,603,800 | $18,379,000 | $18,612,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 668,500 | 793,000 | 717,900 | 875,800 | 660,900 |
| Accrued Expenses | 878,000 | 835,800 | 770,400 | 871,200 | 757,500 |
| TOTAL | $2,629,200 | $2,716,800 | $2,064,600 | $3,330,200 | $3,412,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,082,500 | 5,077,300 | 5,568,700 | 5,331,200 | 5,352,100 |
| Deferred Revenues | 391,600 | 398,000 | 388,300 | 392,200 | 403,100 |
| Other Non-Current Liabilities | 1,346,800 | 1,372,600 | 1,208,400 | 1,207,800 | 1,244,400 |
| TOTAL | $6,935,500 | $6,870,400 | $7,231,800 | $6,996,600 | $7,030,300 |
| Total Liabilities | $9,564,700 | $9,587,200 | $9,296,400 | $10,326,800 | $10,442,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,900 | 83,100 | 83,700 | 83,700 | 83,639 |
| Common Shares | 7,500 | 7,500 | 7,600 | 7,600 | 7,600 |
| Retained earnings | 8,698,400 | 8,498,000 | 8,455,600 | 8,303,400 | 8,275,800 |
| Other shareholders' equity | -42,000 | -34,600 | -191,600 | -261,600 | -113,200 |
| TOTAL | $8,696,900 | $8,472,700 | $8,307,400 | $8,052,200 | $8,170,200 |
| Total Liabilities And Equity | $18,261,600 | $18,059,900 | $17,603,800 | $18,379,000 | $18,612,500 |